Cash flow Rheon Automatic Machinery Co., Ltd.

Equities

6272

JP3979400003

Industrial Machinery & Equipment

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-01-21 EST			5-day change	1st Jan Change
1,501.00 ^JPY	+0.67%		+0.60%	+3.23%

11-11	Rheon Automatic Machinery Co., Ltd. Announces Interim Dividend for the Fiscal Year Ending March 31, 2026, Payable on December 11, 2025 and Revises Dividend Guidance for the Fiscal Year Ending March 31, 2026	CI
11-11	Rheon Automatic Machinery Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI

8.AF5eY8zv0HsM34ER8KvS-Qm88KCwqVXbLhBGcYRhd8E.Mg0kEK6ZlExH8rJiqpvkrEfxnu7IxAWwVGkzMN0tI4dOFBkIqb6BDmjmtQ

Published financial data: RHEON AUTOMATIC MACHINERY CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	22.28B	26.58B	35.27B	37.7B	39.21B
Total Revenues	22.28B	26.58B	35.27B	37.7B	39.21B
Cost of Goods Sold, Total	12.36B	15.78B	20.7B	20.91B	21.42B
Gross Profit	9.92B	10.8B	14.57B	16.79B	17.79B
Selling General & Admin Expenses, Total	7.46B	8.62B	10.28B	10.57B	11.13B
Provision for Bad Debts	6M	11M	-7M	4M	3M
R&D Expenses	545M	535M	742M	760M	737M
Depreciation & Amortization - (IS)	502M	539M	538M	573M	623M
Other Operating Expenses, Total	8.52B	9.7B	11.56B	11.91B	12.5B
Operating Income	1.4B	1.1B	3.01B	4.88B	5.3B
Interest Expense, Total	-16M	-14M	-12M	-11M	-11M
Interest And Investment Income	24M	26M	27M	50M	123M
Net Interest Expenses	8M	12M	15M	39M	112M
Currency Exchange Gains (Loss)	42M	86M	38M	19M	-37M
Other Non Operating Income (Expenses)	169M	261M	131M	53M	29M
EBT, Excl. Unusual Items	1.62B	1.46B	3.19B	5B	5.4B
Gain (Loss) On Sale Of Investments	-28M	-	-	-	-
Gain (Loss) On Sale Of Assets	683M	9M	17M	-8M	12M
Asset Writedown	-228M	-	-	-	-
Other Unusual Items	-61M	-30M	-	-	-104M
EBT, Incl. Unusual Items	1.99B	1.44B	3.21B	4.99B	5.31B
Income Tax Expense	381M	-48M	472M	1.31B	1.42B
Earnings From Continuing Operations	1.61B	1.49B	2.74B	3.68B	3.89B
Net Income to Company	1.61B	1.49B	2.74B	3.68B	3.89B
Net Income - (IS)	1.61B	1.49B	2.74B	3.68B	3.89B
Net Income to Common Incl Extra Items	1.61B	1.49B	2.74B	3.68B	3.89B
Net Income to Common Excl. Extra Items	1.61B	1.49B	2.74B	3.68B	3.89B
Per Share Items
Net EPS - Basic	60	55.44	102.1	136.95	144.71
Basic EPS - Continuing Operations	60	55.44	102.1	136.95	144.71
Basic Weighted Average Shares Outstanding	26.8M	26.8M	26.81M	26.83M	26.88M
Net EPS - Diluted	59.9	55.34	101.88	136.72	144.53
Diluted EPS - Continuing Operations	59.9	55.34	101.88	136.72	144.53
Diluted Weighted Average Shares Outstanding	26.86M	26.87M	26.87M	26.88M	26.91M
Normalized Basic EPS	37.85	34.02	74.42	116.34	125.63
Normalized Diluted EPS	37.77	33.94	74.24	116.14	125.44
Dividend Per Share	17	16	31	42	44
Payout Ratio	23.38	32.5	19.58	28.41	29.62
Supplemental Items
EBITDA	2.52B	2.22B	4.18B	6.15B	6.78B
EBITA	1.4B	1.1B	3.01B	4.88B	5.3B
EBIT	1.4B	1.1B	3.01B	4.88B	5.3B
Effective Tax Rate - (Ratio)	19.16	-3.34	14.71	26.31	26.76
Normalized Net Income	1.01B	912M	2B	3.12B	3.38B
Non-Cash Pension Expense	-72.39M	-107M	-111M	-106M	-131M
Supplemental Operating Expense Items
Advertising Expense	87M	133M	318M	348M	307M
Selling and Marketing Expenses	1.36B	2.34B	3.2B	2.97B	3.16B
Research And Development Expense From Footnotes	545M	535M	742M	760M	737M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.48B	10B	11.44B	13.59B	15.78B
Total Cash And Short Term Investments	7.48B	10B	11.44B	13.59B	15.78B
Accounts Receivable, Total	2.68B	2.31B	3.21B	3.21B	4.06B
Total Receivables	2.68B	2.31B	3.21B	3.21B	4.06B
Inventory	5.47B	6.58B	7.37B	7.82B	8.52B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.33B	904M	637M	784M	722M
Total Current Assets	16.96B	19.79B	22.66B	25.4B	29.07B
Net Property Plant And Equipment	13.16B	12.96B	13.49B	14.4B	14.98B
Long-term Investments	2.54B	2.66B	2.88B	3.61B	3.98B
Other Intangibles, Total	1.46B	1.24B	1.18B	1.16B	1.21B
Other Long-Term Assets, Total	1M	1M	2M	1M	1M
Total Assets	34.12B	36.65B	40.21B	44.57B	49.24B
Liabilities
Accounts Payable, Total	741M	1.14B	1.2B	1.29B	1.42B
Accrued Expenses, Total	1.08B	1.2B	1.39B	1.41B	1.47B
Short-term Borrowings	734M	703M	794M	704M	660M
Current Portion of Leases	2M	-	1M	6M	6M
Current Income Taxes Payable	1.19B	1.07B	1.06B	1.25B	1.78B
Other Current Liabilities	1.33B	2.16B	2.5B	2.09B	3.53B
Total Current Liabilities	5.08B	6.27B	6.95B	6.74B	8.87B
Long-Term Debt	1.41B	1.36B	1.14B	903M	737M
Long-Term Leases	1M	-	5M	18M	14M
Deferred Tax Liability Non Current	920M	551M	688M	987M	891M
Other Non Current Liabilities	86M	87M	49M	40M	20M
Total Liabilities	7.49B	8.27B	8.83B	8.69B	10.53B
Common Stock, Total	7.35B	7.35B	7.35B	7.35B	7.35B
Additional Paid In Capital	7.07B	7.08B	7.08B	7.1B	7.18B
Retained Earnings	14.59B	15.58B	17.78B	20.41B	23.14B
Treasury Stock	-773M	-771M	-770M	-750M	-720M
Comprehensive Income and Other	-1.6B	-857M	-55M	1.77B	1.76B
Total Common Equity	26.63B	28.38B	31.38B	35.88B	38.71B
Total Equity	26.63B	28.38B	31.38B	35.88B	38.71B
Total Liabilities And Equity	34.12B	36.65B	40.21B	44.57B	49.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	26.8M	26.81M	26.81M	26.85M	26.91M
ECS Total Common Shares Outstanding	26.8M	26.8M	26.81M	26.85M	26.91M
Book Value / Share	993.83	1.06K	1.17K	1.34K	1.44K
Tangible Book Value	25.17B	27.14B	30.21B	34.72B	37.5B
Tangible Book Value Per Share	939.24	1.01K	1.13K	1.29K	1.39K
Total Debt	2.14B	2.06B	1.94B	1.63B	1.42B
Net Debt	-5.34B	-7.94B	-9.5B	-11.96B	-14.36B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-1.41B	-1.46B	-1.35B	-1.81B	-1.8B
Inventories - Raw Materials, Total	328M	431M	401M	481M	435M
Inventories - Work In Process, Total	975M	1.68B	1.63B	1.34B	1.98B
Inventories - Finished Goods, Total	4.17B	4.47B	5.34B	6B	6.1B
Inventories - Others	1M	2M	1M	1M	1M
Full Time Employees	1.06K	1.1K	1.12K	1.08K	1.08K
Accumulated Allowance for Doubtful Accounts (Supple)	14M	24M	21M	27M	35M
Order Backlog	3.75B	7.39B	8.64B	7.01B	10.24B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	1.99B	1.44B	3.21B	4.99B	5.31B
Depreciation & Amortization - CF	1.11B	1.12B	1.18B	1.27B	1.48B
Depreciation & Amortization, Total	1.11B	1.12B	1.18B	1.27B	1.48B
(Gain) Loss From Sale Of Asset	-447M	-18M	2M	22M	7M
(Gain) Loss on Sale of Investments - (CF)	28M	-	-	-	-
Other Operating Activities, Total	-675M	157M	-206M	-1.11B	-1.09B
Change In Accounts Receivable	101M	436M	-815M	156M	-887M
Change In Inventories	455M	-905M	-596M	-142M	-733M
Change In Accounts Payable	1M	443M	-31M	-125M	194M
Change in Other Net Operating Assets	151M	973M	352M	-463M	1.46B
Cash from Operations	2.72B	3.65B	3.09B	4.59B	5.75B
Capital Expenditure	-1.37B	-1.01B	-765M	-1.08B	-1.71B
Sale of Property, Plant, and Equipment	1.26B	285M	1M	2M	1M
Sale (Purchase) of Intangible assets	-400M	-13M	-351M	-377M	-270M
Investment in Marketable and Equity Securities, Total	-7M	-7M	-7M	-8M	-8M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-54M	1M	9M	7M	-9M
Cash from Investing	-573M	-748M	-1.11B	-1.46B	-2B
Short Term Debt Issued, Total	-	-	140M	-	-
Long-Term Debt Issued, Total	1.2B	350M	100M	100M	160M
Total Debt Issued	1.2B	350M	240M	100M	160M
Short Term Debt Repaid, Total	-68M	-108M	-	-100M	-40M
Long-Term Debt Repaid, Total	-368M	-322M	-378M	-324M	-330M
Total Debt Repaid	-436M	-430M	-378M	-424M	-370M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-376M	-483M	-536M	-1.04B	-1.15B
Common & Preferred Stock Dividends Paid	-376M	-483M	-536M	-1.04B	-1.15B
Other Financing Activities, Total	-8M	-2M	-3M	-4M	-7M
Cash from Financing	380M	-565M	-677M	-1.37B	-1.37B
Foreign Exchange Rate Adjustments	141M	181M	139M	389M	-199M
Miscellaneous Cash Flow Adjustments	-	-1M	-	-1M	-1M
Net Change in Cash	2.66B	2.52B	1.44B	2.15B	2.19B
Supplemental Items
Cash Interest Paid	16M	14M	13M	11M	11M
Cash Income Tax Paid (Refund)	675M	-156M	207M	1.11B	1.09B
Levered Free Cash Flow	-186M	1.69B	1.08B	2.15B	3.49B
Unlevered Free Cash Flow	-176M	1.7B	1.09B	2.15B	3.5B
Change In Net Working Capital	392M	-914M	849M	709M	-684M
Net Debt Issued / Repaid	764M	-80M	-138M	-324M	-210M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.67	1.94	4.89	7.2	7.06
Return on Total Capital	3.19	2.32	5.9	8.62	8.53
Return On Equity %	6.25	5.4	9.16	10.93	10.43
Return on Common Equity	6.25	5.4	9.16	10.93	10.43
Margin Analysis
Gross Profit Margin %	44.53	40.63	41.3	44.54	45.37
SG&A Margin	33.5	32.41	29.16	28.04	28.39
EBITDA Margin %	11.29	8.37	11.86	16.31	17.3
EBITA Margin %	6.3	4.14	8.53	12.95	13.51
EBIT Margin %	6.3	4.14	8.53	12.95	13.51
Income From Continuing Operations Margin %	7.22	5.59	7.76	9.75	9.92
Net Income Margin %	7.22	5.59	7.76	9.75	9.92
Net Avail. For Common Margin %	7.22	5.59	7.76	9.75	9.92
Normalized Net Income Margin	4.55	3.43	5.66	8.28	8.61
Levered Free Cash Flow Margin	-0.84	6.36	3.07	5.69	8.9
Unlevered Free Cash Flow Margin	-0.79	6.39	3.09	5.71	8.92
Asset Turnover
Asset Turnover	0.68	0.75	0.92	0.89	0.84
Fixed Assets Turnover	1.65	2.04	2.67	2.7	2.67
Receivables Turnover (Average Receivables)	7.84	10.67	12.78	11.74	10.79
Inventory Turnover (Average Inventory)	2.22	2.62	2.97	2.75	2.62
Short Term Liquidity
Current Ratio	3.34	3.15	3.26	3.77	3.28
Quick Ratio	2	1.96	2.11	2.49	2.24
Operating Cash Flow to Current Liabilities	0.53	0.58	0.44	0.68	0.65
Days Sales Outstanding (Average Receivables)	46.53	34.2	28.56	31.17	33.82
Days Outstanding Inventory (Average Inventory)	164.47	139.4	123.02	132.96	139.17
Average Days Payable Outstanding	23.7	20.37	19.86	21.26	22.32
Cash Conversion Cycle (Average Days)	187.31	153.23	131.71	142.87	150.67
Long Term Solvency
Total Debt/Equity	8.05	7.28	6.18	4.55	3.66
Total Debt / Total Capital	7.45	6.78	5.82	4.35	3.53
LT Debt/Equity	5.28	4.8	3.64	2.57	1.94
Long-Term Debt / Total Capital	4.89	4.47	3.43	2.46	1.87
Total Liabilities / Total Assets	21.95	22.58	21.95	19.5	21.38
EBIT / Interest Expense	87.75	78.57	250.67	444	481.64
EBITDA / Interest Expense	157.25	158.86	348.67	559.18	616.64
(EBITDA - Capex) / Interest Expense	71.38	86.43	284.92	461	460.91
Total Debt / EBITDA	0.85	0.93	0.46	0.27	0.21
Net Debt / EBITDA	-2.12	-3.57	-2.27	-1.94	-2.12
Total Debt / (EBITDA - Capex)	1.88	1.71	0.57	0.32	0.28
Net Debt / (EBITDA - Capex)	-4.68	-6.56	-2.78	-2.36	-2.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-17.16	19.32	32.66	6.9	4.01
Gross Profit, 1 Yr. Growth %	-19.45	8.87	34.86	15.28	5.96
EBITDA, 1 Yr. Growth %	-35.6	-11.61	88.13	47.01	10.27
EBITA, 1 Yr. Growth %	-51.37	-21.65	173.45	62.37	8.48
EBIT, 1 Yr. Growth %	-51.37	-21.65	173.45	62.37	8.48
Earnings From Cont. Operations, 1 Yr. Growth %	-18.42	-7.59	84.19	34.27	5.82
Net Income, 1 Yr. Growth %	-18.42	-7.59	84.19	34.27	5.82
Normalized Net Income, 1 Yr. Growth %	-45.5	-10.1	118.78	56.48	8.15
Diluted EPS Before Extra, 1 Yr. Growth %	-18.45	-7.61	84.1	34.2	5.71
Accounts Receivable, 1 Yr. Growth %	-10.95	-13.83	39.33	-0.12	26.49
Inventory, 1 Yr. Growth %	-3.35	20.24	12.02	6.06	8.89
Net Property, Plant and Equip., 1 Yr. Growth %	-4.58	-1.49	4.03	6.77	4.01
Total Assets, 1 Yr. Growth %	7.9	7.41	9.72	10.85	10.47
Tangible Book Value, 1 Yr. Growth %	7.95	7.83	11.3	14.95	8
Common Equity, 1 Yr. Growth %	7.31	6.55	10.6	14.33	7.89
Cash From Operations, 1 Yr. Growth %	112.61	34.36	-15.27	48.53	25.33
Capital Expenditures, 1 Yr. Growth %	-30.92	-26.2	-24.56	41.18	58.61
Levered Free Cash Flow, 1 Yr. Growth %	-92.07	-1.01K	-35.88	98.12	62.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-92.47	-1.06K	-35.77	97.39	62.4
Dividend Per Share, 1 Yr. Growth %	-22.73	-5.88	93.75	35.48	4.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.48	-0.58	25.82	19.09	5.44
Gross Profit, 2 Yr. CAGR %	-13.6	-6.36	21.17	24.69	10.52
EBITDA, 2 Yr. CAGR %	-23.1	-24.55	28.96	66.31	27.33
EBITA, 2 Yr. CAGR %	-35.09	-38.27	46.37	110.71	32.71
EBIT, 2 Yr. CAGR %	-35.09	-38.27	46.37	110.71	32.71
Earnings From Cont. Operations, 2 Yr. CAGR %	-19.35	-13.17	30.47	57.26	19.2
Net Income, 2 Yr. CAGR %	-19.35	-13.17	30.47	57.26	19.2
Normalized Net Income, 2 Yr. CAGR %	-31.88	-30.01	40.24	85.03	30.09
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.37	-13.2	30.42	57.18	19.11
Accounts Receivable, 2 Yr. CAGR %	4.75	-12.4	9.58	17.97	12.4
Inventory, 2 Yr. CAGR %	-1.76	7.8	16.06	9	7.47
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.14	-3.04	1.23	5.39	5.38
Total Assets, 2 Yr. CAGR %	2.98	7.65	8.55	10.28	10.66
Tangible Book Value, 2 Yr. CAGR %	3.99	7.89	9.55	13.11	11.42
Common Equity, 2 Yr. CAGR %	5.64	6.93	8.55	12.45	11.06
Cash From Operations, 2 Yr. CAGR %	-17.05	69.02	6.7	12.18	36.44
Capital Expenditures, 2 Yr. CAGR %	9.07	-28.6	-25.38	3.2	49.64
Levered Free Cash Flow, 2 Yr. CAGR %	-76.17	-15.25	141.03	12.71	79.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	-76.88	-14.85	148.62	12.6	79.04
Dividend Per Share, 2 Yr. CAGR %	-22.08	-14.72	35.04	62.02	19.14
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.24	-2.21	9.45	19.17	13.83
Gross Profit, 3 Yr. CAGR %	-7.84	-6.68	5.75	19.17	18.1
EBITDA, 3 Yr. CAGR %	-17.37	-19.45	2.31	34.71	45.02
EBITA, 3 Yr. CAGR %	-26.92	-30.89	1.38	51.52	68.88
EBIT, 3 Yr. CAGR %	-26.92	-30.89	1.38	51.52	68.88
Earnings From Cont. Operations, 3 Yr. CAGR %	-15.75	-15.6	11.57	31.72	37.81
Net Income, 3 Yr. CAGR %	-15.75	-15.6	11.57	31.72	37.81
Normalized Net Income, 3 Yr. CAGR %	-24.03	-25.28	2.34	45.46	54.7
Diluted EPS Before Extra, 3 Yr. CAGR %	-15.78	-15.63	11.52	31.66	37.71
Accounts Receivable, 3 Yr. CAGR %	-10.92	-1.85	2.26	6.24	20.74
Inventory, 3 Yr. CAGR %	-2.54	5.08	9.19	12.62	8.96
Net Property, Plant and Equip., 3 Yr. CAGR %	3.58	-0.59	-0.74	3.05	4.93
Total Assets, 3 Yr. CAGR %	2.73	4.43	8.33	9.31	10.34
Tangible Book Value, 3 Yr. CAGR %	4.52	5.25	9.02	11.32	11.38
Common Equity, 3 Yr. CAGR %	6.13	5.94	8.14	10.45	10.91
Cash From Operations, 3 Yr. CAGR %	-12.15	-2.58	34.27	19.14	16.4
Capital Expenditures, 3 Yr. CAGR %	9.83	-4.25	-27.28	-7.71	19.1
Levered Free Cash Flow, 3 Yr. CAGR %	-56.12	-19.88	-22.77	125.78	27.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-57	-19.86	-22.49	130.21	27.22
Dividend Per Share, 3 Yr. CAGR %	-17.25	-17.02	12.11	35.19	40.1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.36	0.88	4.79	5.81	7.83
Gross Profit, 5 Yr. CAGR %	-2.77	-1.44	2.82	4.79	7.63
EBITDA, 5 Yr. CAGR %	-5.05	-11.38	-1.27	7.65	11.66
EBITA, 5 Yr. CAGR %	-9.95	-19.27	-3.51	7.95	12.91
EBIT, 5 Yr. CAGR %	-9.95	-19.27	-3.51	7.95	12.91
Earnings From Cont. Operations, 5 Yr. CAGR %	-1.22	-6.94	0.35	8.25	14.56
Net Income, 5 Yr. CAGR %	-1.22	-6.94	0.35	8.25	14.56
Normalized Net Income, 5 Yr. CAGR %	-8.33	-15.24	-2.92	7.38	12.65
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.66	-6.98	0.32	8.21	14.5
Accounts Receivable, 5 Yr. CAGR %	-0.1	-7.4	-3.23	5.64	6.2
Inventory, 5 Yr. CAGR %	6.44	6.28	4.51	6.63	8.5
Net Property, Plant and Equip., 5 Yr. CAGR %	1.94	1.5	2.63	1.76	1.66
Total Assets, 5 Yr. CAGR %	5.78	5.41	5.02	6.73	9.26
Tangible Book Value, 5 Yr. CAGR %	6.64	6.19	6.51	8.33	9.97
Common Equity, 5 Yr. CAGR %	7.52	6.92	7.09	8.5	9.3
Cash From Operations, 5 Yr. CAGR %	-3.23	12.44	-5.04	3.07	35.13
Capital Expenditures, 5 Yr. CAGR %	8.95	-1.14	-5.9	-1.33	-2.94
Levered Free Cash Flow, 5 Yr. CAGR %	-36.57	23.11	-13.27	-8.16	8.21
Unlevered Free Cash Flow, 5 Yr. CAGR %	-37.41	22.67	-13.24	-8.19	8.34
Dividend Per Share, 5 Yr. CAGR %	-2.2	-7.79	0.66	8.45	14.87